Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide 15 amino acids long derived from a protective protein naturally found in human gastric juice
Unlike many endogenous peptides, BPC-157 demonstrates stability in both acidic and physiological pH environments, which has made it a durable research tool across multiple tissue model systems
Targeted Defense - Proactive Prevention -Enhanced Immunity - Convenient and Effective: Don't leave your health to chance take proactive steps to protect yourself against germs and viruses with our Eradicate IV Treatment
Int J Health Sci (Qassim) (2018) 12:8893
Cathy Testimonials It was great having options close to work and home